Graciela Corona

Graciela Corona is an experienced talent acquisition professional currently serving as the Interim Head of Talent Acquisition at 89bio, a clinical-stage biopharmaceutical company focused on innovative therapies for liver and cardiometabolic diseases. Additionally, Graciela is a Senior Talent Acquisition Partner at CytomX Therapeutics, where efforts target innovative cancer treatments, and a Senior Talent Acquisition Partner at Christine Mathews Consulting, specializing in biotech, pharmaceutical, and medical device sectors. Previous roles include Senior Recruiting Consultant at Vera Therapeutics, Talent Acquisition-Sourcing Consultant at Medivation, and Human Resources Consultant at Sangamo BioSciences. Graciela’s career began at Onyx Pharmaceuticals, where numerous positions were held, ranging from Recruiter II to Executive Assistant. Educational qualifications include a Bachelor of Science in Business Management from the University of Phoenix and studies at San Francisco State University.